2018
DOI: 10.1182/blood-2017-07-741025
|Get access via publisher |Cite
|
Sign up to set email alerts
VSports最新版本 -

The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy

"V体育安卓版" Abstract: In recent years, monoclonal antibodies (mAbs) able to reinvigorate antitumor T-cell immunity have heralded a paradigm shift in cancer treatment. The most high profile of these mAbs block the inhibitory checkpoint receptors PD-1 and CTLA-4 and have improved life expectancy for patients across a range of tumor types. However, it is becoming increasingly clear that failure of some patients to respond to checkpoint inhibition is attributable to inadequate T-cell priming. For full T-cell activation, 2 signals must … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
176
0
3

Year Published

2019
2019
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations

Cited by 242 publications (V体育官网入口)

(185 citation statements)
references

References 126 publications (VSports在线直播)

6
176
0
3
Order By: Relevance